SFM
XFOR icon

Sphera Funds Management’s X4 Pharmaceuticals XFOR Stock Holding History

Sphera Funds Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-18,860
Closed -$5.27M – 118
2020
Q2 		$5.27M Sell
18,860
-10,247
-35% -$2.81M 0.5% 50
2020
Q1 		$8.73M Buy
29,107
+5,107
+21% +$1.45M 1.09% 21
2019
Q4 		$7.7M Buy
24,000
+22,420
+1,419% +$8.04M 0.63% 32
2019
Q3 		$602K Hold
1,580
– – 0.09% 75
2019
Q2 		$711K Buy
+1,580
New +$803K 0.1% 81
2018
Q2 		– Sell
-639
Closed -$2.63M – 128
2018
Q1 		$2.63M Sell
639
-857
-57% -$2.49M 0.4% 69
2017
Q4 		$3.44M Buy
+1,496
New +$3.78M 0.4% 60

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Sphera Funds Management's XFOR Position: Q3 2020 in Review

Sphera Funds Management sold out of X4 Pharmaceuticals (XFOR) in Q3 2020, closing a stake of 18,860 shares — an estimated $5.27M sold.

Sphera Funds Management first reported a position in XFOR in Q4 2017 and held it in 7 quarters. The position peaked at $8.73M in Q1 2020. 53 funds tracked by Wall St. Rank hold XFOR as of Q3 2020.

  • Sphera Funds Management reported no remaining X4 Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Sphera Funds Management sold 18,860 X4 Pharmaceuticals shares in Q3 2020, an estimated $5.27M.
  • Sphera Funds Management first reported a position in X4 Pharmaceuticals in Q4 2017 and held it in 7 quarters.
  • Sphera Funds Management's X4 Pharmaceuticals position peaked at $8.73M in Q1 2020.
  • 53 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2020.

Based on Sphera Funds Management's 13F filing for Q3 2020, filed 12 Nov 2020.